|
Volumn 15, Issue 8, 2009, Pages 614-616
|
Focal brain glucose hypermetabolism in myoclonus-dystonia syndrome caused by an epsilon-sarcoglycan gene mutation
|
Author keywords
Dystonia plus syndrome; Epsilon sarcoglycan gene; Myoclonus; Positron emission tomography
|
Indexed keywords
BACLOFEN;
BOTULINUM TOXIN;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLONAZEPAM;
CYTOSINE;
EPSILON SARCOGLYCAN;
FLUORODEOXYGLUCOSE F 18;
GLUCOSE;
LEVODOPA;
THYMINE;
ADULT;
ANXIETY DISORDER;
BRAIN METABOLISM;
CASE REPORT;
CERVICAL SPINE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DEPRESSION;
DNA SEQUENCE;
DRUG TREATMENT FAILURE;
FEMALE;
GENE MUTATION;
GENETIC ANALYSIS;
GLUCOSE BRAIN LEVEL;
GLUCOSE METABOLISM;
HUMAN;
HYPERMETABOLISM;
IMAGE ANALYSIS;
INVOLUNTARY MOVEMENT;
LETTER;
MALE;
MYOCLONUS DYSTONIA;
NEUROIMAGING;
NEUROPSYCHIATRY;
NUCLEIC ACID BASE SUBSTITUTION;
NUCLEOTIDE SEQUENCE;
PEDIGREE ANALYSIS;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SEQUENCE ANALYSIS;
SINGLE NUCLEOTIDE POLYMORPHISM;
TAIWAN;
ADULT;
BRAIN;
DYSTONIC DISORDERS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
GLUCOSE;
GLUCOSE METABOLISM DISORDERS;
HUMANS;
MUTATION;
MYOCLONUS;
PEDIGREE;
SARCOGLYCANS;
SYNDROME;
|
EID: 68349136717
PISSN: 13538020
EISSN: None
Source Type: Journal
DOI: 10.1016/j.parkreldis.2008.11.007 Document Type: Letter |
Times cited : (3)
|
References (5)
|